{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:48:07Z","timestamp":1790729287716,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00415-020-10269-9","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T04:05:47Z","timestamp":1603253147000},"page":"1266-1275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["18F-FDOPA-PET in pseudotumoral brain lesions"],"prefix":"10.1007","volume":"268","author":[{"given":"Dimitri","family":"Renard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Collombier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Laurent-Chabalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Le Floch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan El","family":"Fertit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Thouvenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Sebastien","family":"Guillamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"10269_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/neuonc\/now058","volume":"18","author":"NL Albert","year":"2016","unstructured":"Albert NL, Weller M, Suchorska B et al (2016) Response assessment in neuro-oncology working group and european association for neuro-oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol 18:1199\u20131208","journal-title":"Neuro Oncol"},{"key":"10269_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40336-017-0225-z","volume":"5","author":"CP Filss","year":"2017","unstructured":"Filss CP, Cicone F, Shah NJ, Galldiks N, Langen KJ (2017) Amino acid PET and MR perfusion imaging in brain tumours. Clin Transl Imaging 5:209\u2013223","journal-title":"Clin Transl Imaging"},{"key":"10269_CR3","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2967\/jnumed.114.140608","volume":"55","author":"C Lapa","year":"2014","unstructured":"Lapa C, Linsenmann T, Monoranu CM et al (2014) Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients. J Nucl Med 55:1611\u20131616","journal-title":"J Nucl Med"},{"key":"10269_CR4","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00259-003-1259-1","volume":"30","author":"A Becherer","year":"2003","unstructured":"Becherer A, Karanikas G, Szab\u00f3 M et al (2003) Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine. Eur J Nucl Med Mol Imaging 30:1561\u20131567","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10269_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/neuonc\/not199","volume":"16","author":"C Kratochwil","year":"2014","unstructured":"Kratochwil C, Combs SE, Leotta K et al (2014) Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors. Neuro Oncol 16:434\u2013440","journal-title":"Neuro Oncol"},{"key":"10269_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/RLU.0000000000001540","volume":"42","author":"C Bund","year":"2017","unstructured":"Bund C, Heimburger C, Imperiale A et al (2017) FDOPA PET-CT of nonenhancing brain tumors. Clin Nucl Med 42:250\u2013257","journal-title":"Clin Nucl Med"},{"key":"10269_CR7","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1097\/RLU.0000000000002007","volume":"43","author":"G Morana","year":"2018","unstructured":"Morana G, Bottoni G, Mancardi MM, Verrico A, Piccardo A (2018) Seizure-induced increased 18F-DOPA uptake in a child with diffuse astrocytoma and transient brain mri abnormalities related to status epilepticus. Clin Nucl Med 43:e149\u2013e150","journal-title":"Clin Nucl Med"},{"key":"10269_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2967\/jnumed.112.109603","volume":"54","author":"M Rapp","year":"2013","unstructured":"Rapp M, Heinzel A, Galldiks N et al (2013) Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma. J Nucl Med 54:229\u2013235","journal-title":"J Nucl Med"},{"key":"10269_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/neuonc\/nos300","volume":"15","author":"M Hutterer","year":"2013","unstructured":"Hutterer M, Nowosielski M, Putzer D et al (2013) [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma. Neuro Oncol 15:341\u2013351","journal-title":"Neuro Oncol"},{"key":"10269_CR10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1186\/s12885-019-5938-0","volume":"19","author":"J Xiao","year":"2019","unstructured":"Xiao J, Jin Y, Nie J, Chen F, Ma X (2019) Diagnostic and grading accuracy of 18F-FDOPA PET and PET\/CT in patients with gliomas: a systematic review and meta-analysis. BMC Cancer 19:767","journal-title":"BMC Cancer"},{"key":"10269_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1023\/B:NEON.0000033384.43417.82","volume":"68","author":"F Giammarile","year":"2004","unstructured":"Giammarile F, Cinotti LE, Jouvet A et al (2004) High and low grade oligodendrogliomas (ODG): correlation of amino-acid and glucose uptakes using PET and histological classifications. J Neurooncol 68:263\u2013274","journal-title":"J Neurooncol"},{"key":"10269_CR12","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1097\/00006123-199912000-00001","volume":"45","author":"D Fortin","year":"1999","unstructured":"Fortin D, Cairncross GJ, Hammond RR (1999) Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment. Neurosurgery 45:1279\u20131291","journal-title":"Neurosurgery"},{"key":"10269_CR13","first-page":"2175","volume":"36","author":"T Ogawa","year":"1995","unstructured":"Ogawa T, Hatazawa J, Inugami A et al (1995) Carbon-11-methionine PET evaluation of intracerebral hematoma: distinguishing neoplastic from non-neoplastic hematoma. J Nucl Med 36:2175\u20132179","journal-title":"J Nucl Med"},{"key":"10269_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/RLU.0000000000001318","volume":"41","author":"FF Calabria","year":"2016","unstructured":"Calabria FF, Chiaravalloti A, Jaffrain-Rea ML et al (2016) 18F-DOPA PET\/CT physiological distribution and pitfalls: experience in 215 patients. Clin Nucl Med 41:753\u2013760","journal-title":"Clin Nucl Med"},{"key":"10269_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/01.rlu.0000168368.10150.b3","volume":"30","author":"HJ Hsieh","year":"2005","unstructured":"Hsieh HJ, Lin SH, Chu YK, Chang CP, Wang SJ (2005) F-18 FDG and F-18 FDOPA PET brain imaging in subacute sclerosing panencephalitis. Clin Nucl Med 30:519\u2013520","journal-title":"Clin Nucl Med"},{"key":"10269_CR16","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1097\/RLU.0000000000001912","volume":"43","author":"L Condon","year":"2018","unstructured":"Condon L, Blazak J (2018) Focal 18F-DOPA uptake in brain parenchyma surrounding developmental venous anomalies. Clin Nucl Med 43:e37\u2013e38","journal-title":"Clin Nucl Med"},{"key":"10269_CR17","first-page":"776","volume":"47","author":"FW Floeth","year":"2006","unstructured":"Floeth FW, Pauleit D, Sabel M et al (2006) 18F-FET PET differentiation of ring-enhancing brain lesions. J Nucl Med 47:776\u2013782","journal-title":"J Nucl Med"},{"key":"10269_CR18","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3892\/ol.2016.4189","volume":"11","author":"S Kebir","year":"2016","unstructured":"Kebir S, Gaertner FC, Mueller M et al (2016) 18F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: a case report. Oncol Lett 11:2195\u20132198","journal-title":"Oncol Lett"},{"key":"10269_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2967\/jnumed.113.121418","volume":"55","author":"KJ Lizarraga","year":"2014","unstructured":"Lizarraga KJ, Allen-Auerbach M, Czernin J et al (2014) (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment. J Nucl Med 55:30\u201336","journal-title":"J Nucl Med"},{"key":"10269_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00259-014-2886-4","volume":"42","author":"F Cicone","year":"2015","unstructured":"Cicone F, Minniti G, Romano A et al (2015) Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery. Eur J Nucl Med Mol Imaging 42:103\u2013111","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10269_CR21","first-page":"332","volume":"35","author":"J Hern\u00e1ndez Pinz\u00f3n","year":"2016","unstructured":"Hern\u00e1ndez Pinz\u00f3n J, Mena D, Aguilar M, Biafore F, Recondo G, Bastianello M (2016) Radionecrosis versus disease progression in brain metastasis. Value of (18)F-DOPA PET\/CT\/MRI. Rev Esp Med Nucl Imagen Mol 35:332\u2013325","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10269_CR22","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1097\/RLU.0000000000000383","volume":"39","author":"Q Sala","year":"2014","unstructured":"Sala Q, Metellus P, Taieb D, Kaphan E, Figarella-Branger D, Guedj E (2014) 18F-DOPA, a clinically available PET tracer to study brain inflammation? Clin Nucl Med 39:e283-285","journal-title":"Clin Nucl Med"},{"key":"10269_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29\u201336","journal-title":"Radiology"},{"key":"10269_CR24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837\u2013845","journal-title":"Biometrics"},{"key":"10269_CR25","doi-asserted-by":"publisher","first-page":"e0157139","DOI":"10.1371\/journal.pone.0157139","volume":"11","author":"C Papin-Michault","year":"2016","unstructured":"Papin-Michault C, Bonnetaud C, Dufour M et al (2016) Study of LAT1 expression in brain metastases: towards a better understanding of the results of positron emission tomography using amino acid tracers. PLoS ONE 11:e0157139","journal-title":"PLoS ONE"},{"key":"10269_CR26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.nucmedbio.2013.05.001","volume":"40","author":"MD Piroth","year":"2013","unstructured":"Piroth MD, Prasath J, Willuweit A et al (2013) Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomas. Nucl Med Biol 40:795\u2013800","journal-title":"Nucl Med Biol"},{"key":"10269_CR27","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2967\/jnumed.109.071423","volume":"51","author":"D Salber","year":"2010","unstructured":"Salber D, Stoffels G, Oros-Peusquens AM et al (2010) Comparison of O-(2\u201318F-fluoroethyl)-L-tyrosine and L-3H-methionine uptake in cerebral hematomas. J Nucl Med 51:790\u2013797","journal-title":"J Nucl Med"},{"key":"10269_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.nucmedbio.2006.09.004","volume":"33","author":"D Salber","year":"2006","unstructured":"Salber D, Stoffels G, Pauleit D et al (2006) Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia. Nucl Med Biol 33:1029\u20131035","journal-title":"Nucl Med Biol"},{"key":"10269_CR29","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1097\/RLU.0000000000001873","volume":"4","author":"M Hutterer","year":"2017","unstructured":"Hutterer M, Bumes E, Riemenschneider MJ et al (2017) AIDS-related central nervous system toxoplasmosis with increased 18F-Fluoroethyl-L-Tyrosine amino acid pet uptake due to LAT1\/2 expression of inflammatory cells. Clin Nucl Med 4:e506\u2013e508","journal-title":"Clin Nucl Med"},{"key":"10269_CR30","doi-asserted-by":"publisher","first-page":"e653","DOI":"10.1016\/j.wneu.2018.07.232","volume":"119","author":"P Lohmann","year":"2018","unstructured":"Lohmann P, Piroth MD, Sellhaus B et al (2018) Correlation of dynamic O-(2-[18F]Fluoroethyl) L-tyrosine positron emission tomography, conventional magnetic resonance imaging, and whole-brain histopathology in a pretreated glioblastoma: a postmortem study. World Neurosurg 119:e653\u2013e660","journal-title":"World Neurosurg"},{"key":"10269_CR31","doi-asserted-by":"publisher","first-page":"e753","DOI":"10.1200\/JCO.2010.30.5763","volume":"28","author":"R Pichler","year":"2010","unstructured":"Pichler R, Wurm G, Nussbaumer K, Kalev O, Sily\u00e9 R, Weis S (2010) Sarcoidois and radiation-induced astrogliosis causes pitfalls in neuro-oncologic positron emission tomography imaging by O-(2-[18F]fluoroethyl)-L-tyrosine. J Clin Oncol 28:e753-755","journal-title":"J Clin Oncol"},{"key":"10269_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40658-016-0169-9","volume":"4","author":"OL Munk","year":"2017","unstructured":"Munk OL, Tolbod LP, Hansen SB, Bogsrud TV (2017) Point-spread function reconstructed PET images of sub-centimeter lesions are not quantitative. EJNMMI Phys 4:5","journal-title":"EJNMMI Phys"},{"key":"10269_CR33","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00259-018-4207-9","volume":"46","author":"I Law","year":"2019","unstructured":"Law I, Albert NL, Arbizu J et al (2019) Joint EANM\/EANO\/RANO practice guidelines\/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0. Eur J Nucl Med Mol Imaging 46:540\u2013557","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10269_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neurobiolaging.2008.05.005","volume":"31","author":"Y Kumakura","year":"2010","unstructured":"Kumakura Y, Vernaleken I, Buchholz HG et al (2010) Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study. Neurobiol Aging 31:447\u2013463","journal-title":"Neurobiol Aging"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10269-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10269-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10269-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T23:36:21Z","timestamp":1634772981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10269-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10269"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10269-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"assertion":[{"value":"29 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}